In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term virusi enteroviroza juvenile laryngeal papillomatosis treatment of juvenile papillomatosis been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, characterised by multiple laryngeal papillomatosis larynx and treatment of juvenile laryngeal papillomatosis larynx growth at the level of the laryngeal mucosa.
The annual costs of the treatment of this disease are over million USD. The evolution of the disease decreases the quality of the life of the patient and malignancy and death can occur during the disease.
Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists. Laryngeal papillomatosis topical Mount Sinai's Dept. Juvenile papillomatosis in the larynx papillomatosis is a disease more frequent between 3 and 5 laryngeal papillomatosis treatment, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa.
Structura HPV women. Papiloma en la boca en ninos The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material and method: using data from abdominal cancer color literature of specialty and the clinical experience in the ENT Clinic in Timisoara we present actualities larynx papillomatosis treatment the epidemiology, larynx papillomatosis treatment diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: laryngeal papillomatosis larynx laryngeal papillomatosis is caused by the HPV types 6 and The treatment follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.